» Articles » PMID: 22723523

IFN-γ-producing CD4+ T Cells Promote Experimental Cerebral Malaria by Modulating CD8+ T Cell Accumulation Within the Brain

Overview
Journal J Immunol
Date 2012 Jun 23
PMID 22723523
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that IFN-γ is required for the development of experimental cerebral malaria (ECM) during Plasmodium berghei ANKA infection of C57BL/6 mice. However, the temporal and tissue-specific cellular sources of IFN-γ during P. berghei ANKA infection have not been investigated, and it is not known whether IFN-γ production by a single cell type in isolation can induce cerebral pathology. In this study, using IFN-γ reporter mice, we show that NK cells dominate the IFN-γ response during the early stages of infection in the brain, but not in the spleen, before being replaced by CD4(+) and CD8(+) T cells. Importantly, we demonstrate that IFN-γ-producing CD4(+) T cells, but not innate or CD8(+) T cells, can promote the development of ECM in normally resistant IFN-γ(-/-) mice infected with P. berghei ANKA. Adoptively transferred wild-type CD4(+) T cells accumulate within the spleen, lung, and brain of IFN-γ(-/-) mice and induce ECM through active IFN-γ secretion, which increases the accumulation of endogenous IFN-γ(-/-) CD8(+) T cells within the brain. Depletion of endogenous IFN-γ(-/-) CD8(+) T cells abrogates the ability of wild-type CD4(+) T cells to promote ECM. Finally, we show that IFN-γ production, specifically by CD4(+) T cells, is sufficient to induce expression of CXCL9 and CXCL10 within the brain, providing a mechanistic basis for the enhanced CD8(+) T cell accumulation. To our knowledge, these observations demonstrate, for the first time, the importance of and pathways by which IFN-γ-producing CD4(+) T cells promote the development of ECM during P. berghei ANKA infection.

Citing Articles

Elevated BACE1 and IFNγ+ T Cells in Patients with Cognitive Impairment and the 5xFAD Mouse Model.

Zhan Y, Chen Z, Zheng S, Dai L, Zhang W, Dai Y ACS Chem Neurosci. 2025; 16(3):384-392.

PMID: 39810314 PMC: 11804866. DOI: 10.1021/acschemneuro.4c00565.


Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage non-lethal infection.

Dookie R, Villegas-Mendez A, Cheeseman A, Jones A, Barroso R, Barrett J Infect Immun. 2024; 92(11):e0034524.

PMID: 39324794 PMC: 11556036. DOI: 10.1128/iai.00345-24.


Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis.

Zheng Y, Cai X, Wang D, Chen X, Wang T, Xie Y BMC Psychiatry. 2024; 24(1):593.

PMID: 39227832 PMC: 11370234. DOI: 10.1186/s12888-024-06054-x.


Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?.

Prah D, Laryea-Akrong E J Infect Dis. 2024; 229(6):1913-1918.

PMID: 38349649 PMC: 11175676. DOI: 10.1093/infdis/jiad581.


-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria.

Gaio P, Cramer A, de Melo Oliveira N, Porto S, Kramer L, Nonato Rabelo R Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256880 PMC: 10821074. DOI: 10.3390/ph17010046.


References
1.
OConnor R, Prendergast C, Sabatos C, Lau C, Leech M, Wraith D . Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol. 2008; 181(6):3750-4. PMC: 2619513. DOI: 10.4049/jimmunol.181.6.3750. View

2.
Belnoue E, Potter S, Rosa D, Mauduit M, Gruner A, Kayibanda M . Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008; 30(10):544-53. DOI: 10.1111/j.1365-3024.2008.01053.x. View

3.
Claser C, Malleret B, Gun S, Wong A, Chang Z, Teo P . CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One. 2011; 6(4):e18720. PMC: 3073989. DOI: 10.1371/journal.pone.0018720. View

4.
Reis P, Comim C, Hermani F, Silva B, Barichello T, Portella A . Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 2010; 6(6):e1000963. PMC: 2891838. DOI: 10.1371/journal.ppat.1000963. View

5.
Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J . Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol. 2006; 177(1):36-9. DOI: 10.4049/jimmunol.177.1.36. View